Royal Bank of Canada Sells 1,890,456 Shares of UBS Group AG $UBSMarket Beat·3 hours agoRY+1.78%UBS+3.07%
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology pushbiopharmadive·15 hours agoBIIB-0.62%AZN-1.13%
UBS AG Posts Strong First-Half 2026 Results and Streamlines Interim ReportingTip Ranks·2 hours agoUBS+3.07%
Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanksbenzinga_article·18 hours agoALNY-28.31%AZN-1.13%
UBS CEO defends share buybacks and pushes back against capital proposalsBusinesstimes News·1 day ago, 03:55 AMUBS+3.07%
Daiichi Sankyo, AstraZeneca Datroway wins EU approval for first-line metastatic TNBC in non-immunotherapy patientsPUBT·6 hours agoAZN-1.13%DSNKY+3.11%
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy | AZN Stock NewsStockTitan·14 hours agoAZN-1.13%DSNKY+3.11%
3,455 Shares in Ligand Pharmaceuticals Incorporated $LGND Bought by Hsbc Holdings PLCMarket Beat·4 hours agoLGND+2.87%UBS+3.07%
UBS says 2Q 2026 profit rises on strong wealth inflows, Investment Bank revenue growthPUBT·1 day ago, 02:40 PMUBS+3.07%
Flowserve (NYSE:FLS) Releases Earnings Results, Beats Estimates By $0.09 EPSMarket Beat·1 day ago, 06:41 PMFLS+7.69%UBS+3.07%
UBSG: Strong profit growth, record assets, and near-complete integration drive confidence for 2026Quartr·2 days ago, 04:55 AMUBS+3.07%
